Fingerprint
Dive into the research topics of 'Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically